MD Anderson, Houston Methodist scientists detect new ovarian cancer target

(University of Texas M. D. Anderson Cancer Center) Researchers at Houston Methodist Research Institute and The University of Texas MD Anderson Cancer Center have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer.